Vanda Pharmaceuticals reported 902K in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Akebia Therapeutics AKBA:US $ 33.69M 4.21M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Bluebird Bio BLUE:US $ 0.77M 12.74M
Bristol Myers Squibb BMY:US $ 2163M 26M
Clovis Oncology CLVS:US $ 17.28M 7.72M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Esperion Therapeutics ESPR:US $ 33.97M 10.26M
Halozyme Therapeutics HALO:US $ 55.98M 2.58M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Ligand Pharmaceuticals LGND:US $ 33M 6.95M
Ptc Therapeutics PTCT:US $ 15.61M 0.83M
Puma Biotechnology PBYI:US $ 7.21M 0.41M
Takeda 4502:JP Y 783476M 4328M
Teva Pharmaceutical TEVA:IT 4.17B 195M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vanda Pharmaceuticals VNDA:US 902K 153K
Veracyte VCYT:US $ 9.82M 3.15M